1. Search Result
Search Result
Results for "

2225109-03-3

" in MCE Product Catalog:
Cat. No. Product Name Target Research Areas
  • HY-P99552
    Tafolecimab

    IBI-306

    Ser/Thr Protease Cardiovascular Disease
    Tafolecimab (IBI-306) is a human lgG2 monoclonal antibody that specifically binds PCSK-9 and reduces LDL-C levels by inhibiting PCSK-9-mediated endocytosis of the LDL receptor, which in turn enhances clearance of LDL-C and leads to a reduction in LDL-C levels. Tafolecimab may be used in studies of hypercholesterolaemia.